Inquire Now


We at Excel Life Sciences (ELS) has experience in conducting and supporting oncology clinical trials in India. We take pride in providing one of the largest networks of Investigators & Site Facilitation services across India. The company has operations in many of the country’s leading oncology centres.

ELS widely manages the oncology trials from beginning to study closeout, domestically. After cardiovascular disease, Cancer is the second most common cause of death in India.

In 2017, The ICMR is estimating to have over 17.3 lakh new cases of cancer and over 8.8 lakh deaths due to the disease by 2020 with cancers of breast, lung and cervix topping the list. Breast cancer, cervical cancer, oral cancer, and lung cancer which together constitute 41 per cent of cancer burden in the Indian population. More women in India die from cervical cancer ( every 8 minutes) than in any other country, also breast cancer is the most common among Indian women, as reported in 2018. Tobacco both smoked and smokeless use accounted for approx. 3,17,928 deaths in men and women in 2018. Oral Cancer was among the top three cancers in India, number one among all cancers in men and number three among female cancers.

About 17% of the world’s breast cancer population are in India. Cancer incidence in India is estimated to increase from 90 per 1,00,000 population to 130-170 per 1,00,000 population by 2020. India offers huge opportunity for enrollment for sponsors & pharmaceutical companies for oncology research.

ELS operations provide access to the site management services for clinical trials industry in India. Ranging from extensive oncology infrastructure, administrative requirements, detailed database of site information, clinical trial investigators, demographics and epidemiology data. Furthermore, ELS provides Clinical Operations Managers, Clinical Research Coordinators as well as other cadres of support staff who will support clinical trial sites with site feasibility, Regulatory/IRB support, patient recruitment, enrollment and follow up. We ensure that clinical trials are conducted according to ICH-GCP guidelines and meet the highest standards of ethics and integrity.